Search

everythinglearnresearchcommunity

for

Search:↓

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

Finasteride treats hair loss and reduces prostate cancer risk.

Identifying alopecia types early is crucial for better treatment and quality of life.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Hair loss in alopecia areata can negatively affect sexual quality of life.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Understanding hair health and disorders is important for effective treatment.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Pharmacist-led care significantly improved post-COVID symptoms.

Low-dose minoxidil effectively enhances facial hair with minimal side effects.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Fenugreek is a promising cosmetic ingredient for skin and hair care.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

Researchers identified genes that may affect hair growth in Cashmere goats.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Certain gene variations increase male hair loss risk, influenced by hormone levels.